← Leaderboards
Susan E. Kane
City Of Hope/Beckman Research Institute
$4,623,441
Attributed
$5,249,221
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $739.2K · FY2006–16$1M$750K$500K$250K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$5,249,221 · 5
By mechanism
R01$3,358,643 · 3
R25$1,111,943 · 1
P20$778,635 · 1
Top collaborators
- Jamil A Momand3 shared
- Feimeng Zhou3 shared
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsPublishingEvaluationElementsInsightMonitorNormal Tissue MorphologyRegulationSignal TransductionAffectImageOverexpressionResistanceMediatingDrug ResistanceGene ExpressionCitiesMentorsCollaborationsMinorityLaboratoriesComprehensive Cancer CenterLos AngelesCareer
Grant awards (21)
Macromolecular Interactions of t-Darpp and Darpp-32$307,125
R01 · FY2016 · GM · contact PI
Macromolecular Interactions of t-Darpp and Darpp-32$307,125
R01 · FY2015 · GM · contact PI
City of Hope and the San Gabriel Valley SEPA Collaborative$262,970
R25 · FY2015 · OD · contact PI
Macromolecular Interactions of t-Darpp and Darpp-32$324,420
R01 · FY2014 · GM · contact PI
City of Hope and the San Gabriel Valley SEPA Collaborative$260,288
R25 · FY2014 · OD · contact PI
In Vivo Bioimaging Model to Study Inducible Drug Resistance in Cancer$314,070
R01 · FY2013 · CA · contact PI
City of Hope and the San Gabriel Valley SEPA Collaborative$246,481
R25 · FY2013 · OD · contact PI
In Vivo Bioimaging Model to Study Inducible Drug Resistance in Cancer$93,772
R01 · FY2013 · CA · contact PI
City of Hope and the San Gabriel Valley SEPA Collaborative$84,910
R25 · FY2013 · OD · contact PI
In Vivo Bioimaging Model to Study Inducible Drug Resistance in Cancer$334,117
R01 · FY2012 · CA · contact PI
City of Hope and the San Gabriel Valley SEPA Collaborative$257,294
R25 · FY2012 · OD · contact PI
In Vivo Bioimaging Model to Study Inducible Drug Resistance in Cancer$79,019
R01 · FY2012 · CA · contact PI
In Vivo Bioimaging Model to Study Inducible Drug Resistance in Cancer$334,117
R01 · FY2011 · CA · contact PI
In Vivo Bioimaging Model to Study Inducible Drug Resistance in Cancer$344,450
R01 · FY2010 · CA · contact PI
In Vivo Bioimaging Model to Study Inducible Drug Resistance in Cancer$344,450
R01 · FY2009 · CA · contact PI
CSULA-COH Collaborative to Study Cancer Disparities$118,893
P20 · FY2009 · CA · contact PI
CSULA-COH Collaborative to Study Cancer Disparities$160,733
P20 · FY2008 · CA · contact PI
CSULA-COH Collaborative to Study Cancer Disparities$234,940
P20 · FY2007 · CA · contact PI
CSULA-COH Collaborative to Study Cancer Disparities$264,069
P20 · FY2006 · CA · contact PI
MDR1 GENE THERAPY IN CD34+ CELLS AND SCID MICE$292,244
R01 · FY2001 · CA
MDR1 GENE THERAPY IN CD34+ CELLS AND SCID MICE$283,734
R01 · FY2000 · CA